EMA Adopts a New Pharmaceutical Form of Selumetinib By Ogkologos - December 16, 2025 241 0 Facebook Twitter Google+ Pinterest WhatsApp It is associated with an extension to the existing indication Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR FDA Grants Accelerated Approval to fam-Trastuzumab Deruxtecan-nxki for HER2-Mutated NSCLC September 2, 2022 GreaterGood Has Donated More Than 2 Million Masks to Frontline Workers... December 21, 2020 Can Having Solar Panels or Living Near a Solar Farm Increase... January 4, 2022 Real-World Increase in Biomarker Testing in Lung Cancer Patients, Registry Study... March 23, 2022 Load more HOT NEWS New breast and lung cancer treatments approved in Scotland Happy Nurses Month! Immunotherapy Plus Chemotherapy Helps People With Advanced Nasopharyngeal Cancer: The ASCO... Adding Blinatumomab to Consolidation Chemotherapy Improves OS in Adult Patients in...
